Preliminary report: accurate assays for anti-HIV in urine.

PubWeight™: 2.17‹?› | Rank: Top 2%

🔗 View Article (PMID 1971662)

Published in Lancet on June 09, 1990

Authors

J A Connell1, J V Parry, P P Mortimer, R J Duncan, K A McLean, A M Johnson, M H Hambling, J Barbara, C P Farrington

Author Affiliations

1: PHLS Virus Reference Laboratory, London, UK.

Articles citing this

Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet (2013) 3.42

Prevalence of HIV infection in patients attending an inner city accident and emergency department. BMJ (1994) 2.15

Immunoglobulin G antibody capture enzyme-linked immunosorbent assay: a versatile assay for detection of anti-human immunodeficiency virus type 1 and 2 antibodies in body fluids. J Clin Microbiol (1992) 1.34

Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a brazilian study. J Clin Microbiol (2002) 1.01

Human immunodeficiency virus antibody testing by enzyme-linked fluorescent and western blot assays using serum, gingival-crevicular transudate, and urine samples. J Clin Microbiol (1999) 0.84

Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse. J Clin Microbiol (1994) 0.83

Detection of anti-human immunodeficiency virus type 1 (HIV-1) immunoglobulin G in urine by an ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) with recombinant reverse transcriptase as an antigen. J Clin Microbiol (1994) 0.80

A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Epidemiol Infect (1996) 0.80

HIV infection among family planning clinic attenders in Glasgow: why prevalence has remained low in this general population group. Sex Transm Infect (1998) 0.79

A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium. Eur J Epidemiol (2007) 0.79

Anti-hepatitis A virus immunoglobulin M antibodies in urine samples for rapid diagnosis of outbreaks. Clin Diagn Lab Immunol (2003) 0.76

Evaluation of a commercial enzyme immunoassay for HIV screening in urine. Eur J Clin Microbiol Infect Dis (2004) 0.75

Anti-HIV-1 antibody detection in urine. Med J Armed Forces India (2014) 0.75

Comparison of three assays for HIV antibodies detection in urine to be applied to epidemiological setting. Eur J Epidemiol (1999) 0.75

Articles by these authors

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10

Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75

Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71

Sexual behaviour in Britain: early heterosexual experience. Lancet (2001) 7.62

Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62

Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect (2001) 6.21

Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 5.91

Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29

Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. BMJ (1996) 4.52

Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ (2000) 4.51

Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41

Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ (2000) 4.31

Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31

Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health (2000) 4.25

Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17

Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) (1983) 4.13

Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13

From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ (1998) 4.09

Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet (1987) 3.91

Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86

Human parvovirus arthropathy. Lancet (1985) 3.76

Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71

HIV surveillance by testing saliva. AIDS (1988) 3.43

Antibody capture radioimmunoassay for anti-rubella IgM. J Hyg (Lond) (1981) 3.38

Controlling genital chlamydial infection. BMJ (1996) 3.29

Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ (2007) 3.24

Sexual lifestyles under scrutiny. Nature (1990) 3.19

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02

Isolation of Chlamydia trachomatis from women attending a clinic for sexually transmitted diseases. Br J Vener Dis (1976) 2.97

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89

Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol (1993) 2.85

Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81

Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72

Risk behaviours for HIV infection among injecting drug users attending a drug dependency clinic. BMJ (1989) 2.68

Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill (2008) 2.66

Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56

Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health (1999) 2.55

The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district. Br Med J (Clin Res Ed) (1986) 2.54

Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ (2001) 2.53

Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England, 1991-1992. AIDS (1993) 2.50

Active surveillance of sexual behaviour among homosexual men in London. Commun Dis Public Health (1998) 2.45

Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34

A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ (2001) 2.30

Provision of sex education and early sexual experience: the relation examined. BMJ (1995) 2.21

Attitudes to tracing and notifying contacts of people with HIV infection. BMJ (1992) 2.19

A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol (1986) 2.18

Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16

Prevalence of HIV infection in patients attending an inner city accident and emergency department. BMJ (1994) 2.15

Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Genitourin Med (1986) 2.14

AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13

Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. J Med Virol (1993) 2.11

Letter: Puerperal rubella vaccination and anti-D immunoglobulin. Br Med J (1974) 2.11

Blood transfusion risk: protecting against the unknown. BMJ (1998) 2.10

Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int (2001) 2.09

Maintaining patient access to GUM clinics: is it compatible with appointments? Sex Transm Infect (2003) 2.08

Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08

Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (1993) 2.07

Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect (2004) 2.06

Febrile illness due to a parvovirus. Br Med J (1980) 2.05

Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04

Vaccine coverage: recent trends and future prospects. BMJ (1992) 2.04

Surveillance of sexual behaviour among homosexual men in a central London health authority. Genitourin Med (1997) 2.03

Epidemiology of transmissible diseases after elimination. Am J Epidemiol (2000) 1.98

Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis (1996) 1.98

Trends in sexual behaviour and risk factors for HIV infection among homosexual men, 1984-7. BMJ (1989) 1.97

Methodology of the National Survey of Sexual Attitudes and Lifestyles. J R Stat Soc Ser A Stat Soc (1993) 1.95

Who reports sexual function problems? Empirical evidence from Britain's 2000 National Survey of Sexual Attitudes and Lifestyles. Sex Transm Infect (2005) 1.95

Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol (1976) 1.95

Which anti-HTLV III/LAV assays for screening and confirmatory testing? Lancet (1985) 1.94

Transformation of chloroplast ribosomal RNA genes in Chlamydomonas: molecular and genetic characterization of integration events. Genetics (1990) 1.93

New hepatitis B vaccines. Br Med J (Clin Res Ed) (1985) 1.93

Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang (1969) 1.88

Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86

The 80th year of fifth disease. Br Med J (Clin Res Ed) (1984) 1.86

A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85

Comparison of enzyme immunoassays and cell culture for detecting Chlamydia trachomatis. Genitourin Med (1986) 1.82

Diagnosis of hepatitis A and B by testing saliva. J Med Virol (1989) 1.82

Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81

Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect (2004) 1.79

Characterization of a virus that causes transient aplastic crisis. J Clin Invest (1984) 1.78

Behavioural intervention trials for HIV/STD prevention in schools: are they feasible? Sex Transm Infect (1998) 1.78

Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr (1983) 1.77

Intraoperative left ventricular perforation with false aneurysm formation. Br Heart J (1976) 1.75

Are many women immunized against rubella unnecessarily? J Hyg (Lond) (1981) 1.75

Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem (1996) 1.75

Trends in HIV testing and recording of HIV status in the UK primary care setting: a retrospective cohort study 1995-2005. Sex Transm Infect (2009) 1.74

Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis (1999) 1.74

An evaluation of partner notification for HIV infection in genitourinary medicine clinics in England. AIDS (1998) 1.71

Voluntary universal antenatal HIV testing. Br J Obstet Gynaecol (1996) 1.71

The role and effectiveness of partner notification in STD control: a review. Genitourin Med (1996) 1.68

The accuracy of reported sensitive sexual behaviour in Britain: exploring the extent of change 1990-2000. Sex Transm Infect (2002) 1.67

Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. Hum Genet (1980) 1.66

Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66